BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6749752)

  • 1. Intrathecal dextrose to prevent seizures after metrizamide myelography in dogs.
    Northington JW; Biery DN; Glickman LT
    Invest Radiol; 1982; 17(3):282-3. PubMed ID: 6749752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postmetrizamide myelographic seizures in dogs, using 5% dextrose solution.
    Tamas PM; Walker MA; Paddleford RR; Tinkel SR
    J Am Vet Med Assoc; 1986 Apr; 188(7):710-2. PubMed ID: 3700226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous administration of dextrose or lactated Ringer's solution on seizure development in dogs after cervical myelography with metrizamide.
    Gray PR; Lowrie CT; Wetmore LA
    Am J Vet Res; 1987 Nov; 48(11):1600-2. PubMed ID: 3434904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pentobarbital sodium to reduce seizures in dogs after cervical myelography with metrizamide.
    Gray PR; Indrieri RJ; Lowrie CT
    J Am Vet Med Assoc; 1987 Jun; 190(11):1422-4. PubMed ID: 3610751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of anesthetic regimen on the frequency of seizures after cervical myelography in the dog.
    Gray PR; Indrieri RJ; Lippert AC
    J Am Vet Med Assoc; 1987 Mar; 190(5):527-30. PubMed ID: 3558089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs.
    Puglisi TA; Green RW; Hall CL; Read WK; Green RA; Tangner CH; Mann FA; Hobson HP
    Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of metrizamide myelography.
    Killebrew K; Whaley RA; Hayward JN; Scatliff JH
    Arch Neurol; 1983 Feb; 40(2):78-80. PubMed ID: 6824454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myelography and headache].
    Hammer B
    Wien Med Wochenschr; 1985 Jun; 135(11):259-63. PubMed ID: 3895752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient leakage across the blood-cerebrospinal fluid barrier after intrathecal metrizamide administration to dogs.
    Johnson GC; Fuciu DM; Fenner WR; Krakowka S
    Am J Vet Res; 1985 Jun; 46(6):1303-8. PubMed ID: 3927799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of metrizamide as a myelographic agent in the dog.
    Stowater JL; Kneller SK
    J Am Vet Med Assoc; 1979 Jul; 175(2):191-5. PubMed ID: 500441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective clinical trial comparing metrizamide and iohexol for equine myelography.
    Widmer WR; Blevins WE; Jakovljevic S; Levy M; Teclaw RF; Han CM; Hurd CD
    Vet Radiol Ultrasound; 1998; 39(2):106-9. PubMed ID: 9548136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid changes after iopamidol and metrizamide myelography in clinically normal dogs.
    Widmer WR; DeNicola DB; Blevins WE; Cook JR; Cantwell HD; Teclaw RF
    Am J Vet Res; 1992 Mar; 53(3):396-401. PubMed ID: 1595968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metrizamide compared with iohexol for cervical myelography: a double-blind study.
    Reisin R; Ethier R; de la Sayette V; Melanson D; Eng F
    Can Assoc Radiol J; 1988 Jun; 39(2):107-10. PubMed ID: 2967830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic complications in diabetics after metrizamide lumbar myelography.
    Steiner E; Simon JH; Ekholm SE; Erickson J; Kido DK; Okawara S
    AJR Am J Roentgenol; 1986 May; 146(5):1057-60. PubMed ID: 3485900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia-like syndrome associated with metrizamide myelography.
    Ong RO; Rosenberg H
    Anesth Analg; 1989 Jun; 68(6):795-7. PubMed ID: 2735545
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications associated with the use of iohexol for myelography of the cervical vertebral column in dogs: 66 cases (1988-1990).
    Lewis DD; Hosgood G
    J Am Vet Med Assoc; 1992 May; 200(9):1381-4. PubMed ID: 1601729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asterixis and encephalopathy following metrizamide myelography: investigations into possible mechanisms and review of the literature.
    Bertoni JM; Schwartzman RJ; Van Horn G; Partin J
    Ann Neurol; 1981 Apr; 9(4):366-70. PubMed ID: 7224601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrizamide myelography risk factors: a pseudopsychiatric case presentation.
    Blair R; Lippmann S
    J Clin Psychiatry; 1985 Oct; 46(10):439-40. PubMed ID: 4044535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.